Archive — US — techcrunch
Holmes and Balwani’s appeal falls flat as court upholds fraud convictions
Elizabeth Holmes and Ramesh Balwani's appeals against their fraud convictions regarding Theranos have been denied by the Northern District Court of California, which upheld their prison sentences exceeding 11 and 13 years respectively, alongside a $452 million restitution order.
Key points
- Holmes and Balwani were convicted in 2022 of defrauding investors about Theranos's blood-testing technology.
- Their appeals focused on alleged improper testimony and the inclusion of a damaging government report.
- The court found that although some testimony was improperly categorized, it deemed the errors harmless.
- Holmes and Balwani argued their rights were violated during the trials, which the court dismissed as unfounded.
- Holmes received a sentence of more than 11 years, while Balwani received nearly 13 years and they both started serving in 2023.
Why it matters
- The case illustrates a trend of accountability in Silicon Valley and the tech industry, particularly with companies misrepresenting their technology.
- The Theranos scandal has led to increased regulatory scrutiny and discussions around ethical practices in startups.
- This reflects ongoing trends in 2025 regarding transparency, ethical governance, and investor due diligence in technology ventures.
The court's decision affirms the importance of regulatory oversight and accountability, highlighting a shift in the tech industry towards more stringent legal and ethical standards.